Document Detail

Increment of hematopoietic progenitor cell count as an indicator of efficient autologs stem cell harvest in patients with multiple myeloma.
MedLine Citation:
PMID:  22535685     Owner:  NLM     Status:  Publisher    
We previously showed that hematopoietic progenitor cell (HPC) count is a useful surrogate for the timing of autologs stem cell collection (ASCC). We investigated the role of HPC count increment in predicting the time for optimal ASCC in patients with multiple myeloma (MM). Between May 2002 and January 2011, 138 patients with MM who underwent ASCC after mobilization with cyclophosphamide (4 g/m(2) ) and granulocyte-colony stimulating factor at Asan Medical Center. HPC monitoring was started on the 10th day of cyclophosphamide administration and ASCC was performed when HPC count reached at least 10/mm(3) . Velocity of HPC increment (/mm(3) /day) was calculated as HPC count on the first day of ASCC/number of days from cyclophosphamide infusion to the first day of ASCC. A total of 422 leukapheresis were performed in 136 patients (median per patient: 3; range: 2-8). Of these patients, 131 (94.9%) successfully achieved optimal ASCC (≥5 × 106 CD34+ cells/kg). The median velocity of HPC increment was 2.17/mm(3) /day (range: 0.07-144.2/mm(3) /day). The mean ± standard error numbers of apheresis procedures in patients with velocity of HPC increment ≤2.0/mm(3) /day and >2.0/mm(3) /day were 3.43 ± 0.17 and 2.70 ± 0.11, respectively, and their median times to optimal ASCC were 15 and 13 days, respectively, with a hazard ratio of 0.47 (95% confidence interval, 0.32-0.68; P < 0.001) on multivariate analysis. Therefore, a slower increase of HPC of ≤2.0/mm(3) /day is associated with larger number of apheresis procedures for optimal ASCC. J. Clin. Apheresis 2012. © 2012 Wiley Periodicals, Inc.
Jae-Cheol Jo; Dok Hyun Yoon; Shin Kim; Seongsoo Jang; Chan Jeoung Park; Hyun-Sook Chi; Chan-Sik Park; Jooryung Huh; Sang-Wook Lee; Cheolwon Suh
Related Documents :
10971395 - Pegylated asparaginase (oncaspar) in children with all: drug monitoring in reinduction ...
25246645 - Frequency and time to relapse after discontinuing 6-month therapy with ivig or pulsed m...
21985585 - Clinical characteristics of multiple sclerosis in kuwait data from the new ms registry ...
17760715 - Eradication of helicobacter pylori does not reduce the incidence of gastroduodenal ulce...
13677595 - An evaluation of the analgesic effects of meloxicam in addition to epidural morphine/me...
21796395 - Adjacent-level degeneration after cervical disc arthroplasty versus fusion.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-25
Journal Detail:
Title:  Journal of clinical apheresis     Volume:  -     ISSN:  1098-1101     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8216305     Medline TA:  J Clin Apher     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Extended acute toxicity study of (188) Re-liposome in Rats.
Next Document:  Alberto sols, teacher and mentor of spanish biochemists (1917-1989).